Cardiovascular Morbidity in COPD: A Study of the General Population
Authors:
- Peter LangePLPeter Lange
- Jørgen VestboJVJørgen Vestbo
- Jan Skov JensenJJJan Skov Jensen
- 9 March 2010
- journal article
- research article
- Published by Taylor & Francis in COPD: Journal of Chronic Obstructive Pulmonary Disease
- Vol. 7 (1) , 5-10
Abstract
Although there are a number of studies on the coexistence of heart disease and COPD among patients acutely admitted to hospital, this relationship has not been accurately described in the general population. Especially data on the prevalence of both reduced lung function and impaired left ventricular ejection fraction (LVEF) are sparse. We used data from the 4th examination of The Copenhagen City Heart Study, which comprises 5,890 individuals with data on pulmonary and cardiac symptoms, risk factors for cardiovascular diseases, pulmonary function tests, ECG and relevant medical history. Among the participants a randomly selected subgroup of 3,469 individuals underwent both spirometry and echocardiography. The participants were classified according to COPD stage using the international GOLD staging according to FEV1 in %% of predicted. The prevalence of COPD was 5.7%% for mild COPD (GOLD stage 1), 9.4%% for moderate COPD (GOLD stage 2) and 2.5%% for severe and very severe COPD (GOLD stages 3++4). Individuals with COPD were older and had a higher prevalence of cardiovascular risk factors and a higher prevalence of cardiovascular diseases. Among the echocardiographical findings, only the presence of left ventricular hyperthrophy was significantly more frequent among individuals with COPD (17.7%%) than among participants without COPD (12.1%%.), yet this relationship was no longer significant after statistical adjustment for age and gender. In the general population, subjects with COPD have a higher prevalence of cardiovascular diseases and an unfavourable cardiovascular risk profile compared with individuals without COPD, but this was mainly related to higher age among the participants with COPD.Keywords
This publication has 27 references indexed in Scilit:
- Chronic obstructive pulmonary disease in patients admitted with heart failureJournal of Internal Medicine, 2008
- Relationship between lung function impairment and incidence or recurrence of cardiovascular events in a middle-aged cohortThorax, 2008
- Cardiovascular risk in chronic obstructive pulmonary diseaseRespirology, 2007
- Cardiovascular Disease in Patients with Chronic Obstructive Pulmonary Disease, Saskatchewan CanadaAnnals of Epidemiology, 2006
- Unrecognized heart failure in elderly patients with stable chronic obstructive pulmonary diseaseEuropean Heart Journal, 2005
- Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paperEuropean Respiratory Journal, 2004
- Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and DeathNew England Journal of Medicine, 2004
- Comparison of enalapril versus nifedipine to decrease left ventricular hypertrophy in systemic hypertension (the PRESERVE trial)The American Journal of Cardiology, 1996
- Echocardiographic assessment of left ventricular hypertrophy: Comparison to necropsy findingsThe American Journal of Cardiology, 1986
- Significance of Respiratory Symptoms and the Diagnosis of Chronic Bronchitis in a Working PopulationBMJ, 1959